Obermatt
See Similar Stocks →

Repare Therapeutics

NSQ:NULL · US7602731025
BiotechnologySmall

360° View

no current rank
Price/Sales67
Price/Earnings—
Price/Book82
Dividend Yield—
Revenue Growth96
Profit Growth11
Capital Growth78
TSR 52w77
Leverage91
Liquidity55
Refinancing95
Combined—
Analyst Opinions—
Pro Holdings1
Opinion Changes—
Market Pulse13

Profile

CountryCanada
IndustryBiotechnology
SizeSmall
TypePrivate Company
ExchangeNASDAQGM
Founded2016
Employees44
Websitereparerx.com
ISINUS7602731025
Last UpdateApr 2, 2026
Index & Theme
GeneticsOncologyBiotechnologyHealth CarePharmaceuticalTherapeutics

Description

Repare Therapeutics Inc. operates as a clinical-stage precision oncology company. The company engages in the discovery and development of novel therapeutics. The company uses its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematic…

Similar Stocks

The companies this stock is ranked against.

Compare Repare Therapeutics with its peers
Acrivon Therapeutics
NMQ:ACRV
6
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Zentalis Pharmaceuticals
NMQ:ZNTL
12
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Prelude Therapeutics
NSQ:PRLD
49
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Revolution Medicines
NSQ:RVMD
32
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Immuneering
NMQ:IMRX
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Black Diamond Therapeutics
NSQ:BDTX
21
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →